Tag: Insulin
Low-Glucose Alerts Beneficial for Insulin-Treated Drivers With Diabetes
Low-glucose alerts improve time below range for drivers with T1D and reduce incidence of low glucose for all insulin-treated drivers
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin
Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications
Hybrid closed-loop insulin delivery does not affect rate of severe hypoglycemia and increases rate of ketoacidosis
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
Merilog administered subcutaneously five to 10 minutes before mealtime helps improve glycemic control
Oral Glucose-Lowering Agents Potential Alternatives to Insulin for Gestational Diabetes
Treatment of gestational diabetes with metformin, and glyburide if needed, does not meet noninferiority criteria versus insulin
Technosphere Insulin + Insulin Degludec Noninferior to Usual Care in T1DM
Regimen of inhaled Technosphere insulin plus insulin degludec noninferior for mean hemoglobin A1c
Automated Insulin Delivery System Improves Glycemic Control in Youth
Findings seen among children and adolescents with type 1 diabetes and nonoptimal control with traditional treatment
Biomarkers of Insulin Resistance Are Risk Factors for Aortic Stenosis
Significant associations seen for fasting, 30-min, and 120-min plasma insulin and proinsulin with AS
Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
Recellularization via electroporation therapy found to be feasible and safe
Insulin Resistance Linked to Risk for More Than 30 Diseases
Twenty-six positive, five negative correlations seen, as well as link between insulin resistance and all-cause mortality in women
